Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Elzonris (tagraxofusp-erzs)
i
Other names:
SL-401, DT388IL3 fusion protein, DT388 IL3, DTIL3, IL-3 receptor targeting agent linked to truncated diphtheria toxin payload, NS-401, NS 401, NS401, SL 401, SL401
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(5)
News
Trials
Company:
Menarini, Nippon Shinyaku
Drug class:
CD123 inhibitor, IL-3 antagonist, Elongation factor 2 inhibitor
Related drugs:
‹
MGD006 (6)
MGD024 (1)
SAR443579 (1)
XmAb14045 (1)
AFM28 (0)
CD123 targeted CAR-NK (0)
IGM-2537 (0)
JD023 (0)
JNJ-63709178 (0)
MP0533 (0)
SAR440234 (0)
APVO436 (0)
JNJ-56022473 (0)
amlexanox (1)
D2C7 (0)
VG712 (0)
MGD006 (6)
MGD024 (1)
SAR443579 (1)
XmAb14045 (1)
AFM28 (0)
CD123 targeted CAR-NK (0)
IGM-2537 (0)
JD023 (0)
JNJ-63709178 (0)
MP0533 (0)
SAR440234 (0)
APVO436 (0)
JNJ-56022473 (0)
amlexanox (1)
D2C7 (0)
VG712 (0)
›
Associations
(5)
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Myelodysplastic Syndrome
TP53 mutation
Myelodysplastic Syndrome
venetoclax + tagraxofusp-erzs
Sensitive: C3 – Early Trials
venetoclax + tagraxofusp-erzs
Sensitive
:
C3
venetoclax + tagraxofusp-erzs
Sensitive: C3 – Early Trials
venetoclax + tagraxofusp-erzs
Sensitive
:
C3
TP53 mutation
Myelodysplastic Syndrome
TP53 mutation
Myelodysplastic Syndrome
tagraxofusp-erzs
Sensitive: C3 – Early Trials
tagraxofusp-erzs
Sensitive
:
C3
tagraxofusp-erzs
Sensitive: C3 – Early Trials
tagraxofusp-erzs
Sensitive
:
C3
TP53 mutation
Acute Myelogenous Leukemia
TP53 mutation
Acute Myelogenous Leukemia
venetoclax + tagraxofusp-erzs
Sensitive: C3 – Early Trials
venetoclax + tagraxofusp-erzs
Sensitive
:
C3
venetoclax + tagraxofusp-erzs
Sensitive: C3 – Early Trials
venetoclax + tagraxofusp-erzs
Sensitive
:
C3
TP53 mutation
Acute Myelogenous Leukemia
TP53 mutation
Acute Myelogenous Leukemia
tagraxofusp-erzs
Sensitive: C3 – Early Trials
tagraxofusp-erzs
Sensitive
:
C3
tagraxofusp-erzs
Sensitive: C3 – Early Trials
tagraxofusp-erzs
Sensitive
:
C3
RUNX1 mutation
Acute Myelogenous Leukemia
RUNX1 mutation
Acute Myelogenous Leukemia
tagraxofusp-erzs
Sensitive: D – Preclinical
tagraxofusp-erzs
Sensitive
:
D
tagraxofusp-erzs
Sensitive: D – Preclinical
tagraxofusp-erzs
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login